APO Research
Talk to an analyst

APO RESEARCH · REPORT

Matrine for Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Matrine for Injection Market Outlook and Growth Opportunities 2026

30 December 2025198 pages

Choose your research edition.

Industry ResearchMatrine for Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Matrine for Injection Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Matrine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Matrine for Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Matrine for Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Matrine for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Matrine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Matrine for Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Matrine for Injection market include Chengdu Tiantai Mount Pharmaceutical, Henan Rongcheng Pharmaceutical, Jiuquan Dadeli Pharmaceutical, Nirvana Pharmaceutical, Trifecta Pharma Co. Ltd and CTTQ PHARMA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Matrine for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Matrine for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Matrine for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Matrine for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Matrine for Injection Segment by Company

Chengdu Tiantai Mount Pharmaceutical

Henan Rongcheng Pharmaceutical

Jiuquan Dadeli Pharmaceutical

Nirvana Pharmaceutical

Trifecta Pharma Co. Ltd

CTTQ PHARMA

Matrine for Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Matrine for Injection Segment by Application

Chronic Hepatitis B Treatment

Tumor Radiotherapy

Others

Matrine for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Matrine for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Matrine for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Matrine for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Matrine for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Matrine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Matrine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Matrine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Matrine for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Matrine for Injection industry.

Chapter 3: Detailed analysis of Matrine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Matrine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Matrine for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Matrine for Injection Industry Trends Table 2. Matrine for Injection Industry Drivers Table 3. Matrine for Injection Industry Opportunities and Challenges Table 4. Matrine for Injection Industry Restraints Table 5. Global Matrine for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Matrine for Injection Revenue Share by Company (2021-2026) Table 7. Global Matrine for Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Matrine for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Matrine for Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Matrine for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Matrine for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Matrine for Injection Company, Product Type & Application Table 13. Global Matrine for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Matrine for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intramuscular Injection Table 18. Significant Companies of Intravenous Drip Table 19. Global Matrine for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Matrine for Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Matrine for Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Matrine for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Matrine for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Matrine for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Matrine for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Matrine for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Matrine for Injection Sales Value Share by Type (2021-2026) Table 28. Global Matrine for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Chronic Hepatitis B Treatment Table 30. Significant Companies of Tumor Radiotherapy Table 31. Significant Companies of Others Table 32. Global Matrine for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Matrine for Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Matrine for Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Matrine for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Matrine for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Matrine for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Matrine for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Matrine for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Matrine for Injection Sales Value Share by Application (2021-2026) Table 41. Global Matrine for Injection Sales Value Share by Application (2027-2032) Table 42. Global Matrine for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Matrine for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Matrine for Injection Sales Market Share by Region (2021-2026) Table 45. Global Matrine for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Matrine for Injection Sales Market Share by Region (2027-2032) Table 47. Global Matrine for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Matrine for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Matrine for Injection Sales Value Share by Region (2021-2026) Table 50. Global Matrine for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Matrine for Injection Sales Value Share by Region (2027-2032) Table 52. Global Matrine for Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Matrine for Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Matrine for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Matrine for Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Matrine for Injection Sales Market Share by Country (2021-2026) Table 58. Global Matrine for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Matrine for Injection Sales Market Share by Country (2027-2032) Table 60. Global Matrine for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Matrine for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Matrine for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Matrine for Injection Sales Value Market Share by Country (2027-2032) Table 64. Chengdu Tiantai Mount Pharmaceutical Company Information Table 65. Chengdu Tiantai Mount Pharmaceutical Business Overview Table 66. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio Table 68. Chengdu Tiantai Mount Pharmaceutical Recent Development Table 69. Henan Rongcheng Pharmaceutical Company Information Table 70. Henan Rongcheng Pharmaceutical Business Overview Table 71. Henan Rongcheng Pharmaceutical Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio Table 73. Henan Rongcheng Pharmaceutical Recent Development Table 74. Jiuquan Dadeli Pharmaceutical Company Information Table 75. Jiuquan Dadeli Pharmaceutical Business Overview Table 76. Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio Table 78. Jiuquan Dadeli Pharmaceutical Recent Development Table 79. Nirvana Pharmaceutical Company Information Table 80. Nirvana Pharmaceutical Business Overview Table 81. Nirvana Pharmaceutical Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Nirvana Pharmaceutical Matrine for Injection Product Portfolio Table 83. Nirvana Pharmaceutical Recent Development Table 84. Trifecta Pharma Co. Ltd Company Information Table 85. Trifecta Pharma Co. Ltd Business Overview Table 86. Trifecta Pharma Co. Ltd Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio Table 88. Trifecta Pharma Co. Ltd Recent Development Table 89. CTTQ PHARMA Company Information Table 90. CTTQ PHARMA Business Overview Table 91. CTTQ PHARMA Matrine for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. CTTQ PHARMA Matrine for Injection Product Portfolio Table 93. CTTQ PHARMA Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Matrine for Injection Distributors List Table 97. Matrine for Injection Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Matrine for Injection Product Image Figure 2. Global Matrine for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Matrine for Injection Sales (2021-2032) & (K Units) Figure 5. Global Matrine for Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Matrine for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intramuscular Injection Image Figure 10. Intravenous Drip Image Figure 11. Global Matrine for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Matrine for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Matrine for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Matrine for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Matrine for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Matrine for Injection Sales Value Share by Type (2021-2032) Figure 17. Chronic Hepatitis B Treatment Image Figure 18. Tumor Radiotherapy Image Figure 19. Others Image Figure 20. Global Matrine for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Matrine for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Matrine for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Matrine for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Matrine for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Matrine for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Matrine for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Matrine for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Matrine for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Matrine for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Matrine for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Matrine for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Matrine for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Matrine for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Matrine for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Matrine for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Matrine for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Matrine for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Matrine for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Matrine for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Matrine for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Chronic Hepatitis B Treatment
  • Tumor Radiotherapy
  • Others
Companies covered
  • Chengdu Tiantai Mount Pharmaceutical
  • Henan Rongcheng Pharmaceutical
  • Jiuquan Dadeli Pharmaceutical
  • Nirvana Pharmaceutical
  • Trifecta Pharma Co. Ltd
  • CTTQ PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Matrine for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Matrine for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Matrine for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Matrine for Injection Market Dynamics
  1. 2.1 Matrine for Injection Industry Trends
  2. 2.2 Matrine for Injection Industry Drivers
  3. 2.3 Matrine for Injection Industry Opportunities and Challenges
  4. 2.4 Matrine for Injection Industry Restraints
3 Matrine for Injection Market by Company
  1. 3.1 Global Matrine for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Matrine for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Matrine for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Matrine for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Matrine for Injection Company Ranking (2024-2026)
  6. 3.6 Global Matrine for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Matrine for Injection Company Product Type and Application
  8. 3.8 Global Matrine for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Matrine for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Matrine for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Matrine for Injection Market by Type
  1. 4.1 Matrine for Injection Type Introduction
  2. 4.1.1 Intramuscular Injection
  3. 4.1.2 Intravenous Drip
  4. 4.2 Global Matrine for Injection Sales Volume by Type
  5. 4.2.1 Global Matrine for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Matrine for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Matrine for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Matrine for Injection Sales Value by Type
  9. 4.3.1 Global Matrine for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Matrine for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Matrine for Injection Sales Value Share by Type (2021-2032)
5 Matrine for Injection Market by Application
  1. 5.1 Matrine for Injection Application Introduction
  2. 5.1.1 Chronic Hepatitis B Treatment
  3. 5.1.2 Tumor Radiotherapy
  4. 5.1.3 Others
  5. 5.2 Global Matrine for Injection Sales Volume by Application
  6. 5.2.1 Global Matrine for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Matrine for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Matrine for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Matrine for Injection Sales Value by Application
  10. 5.3.1 Global Matrine for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Matrine for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Matrine for Injection Sales Value Share by Application (2021-2032)
6 Matrine for Injection Regional Sales and Value Analysis
  1. 6.1 Global Matrine for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Matrine for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Matrine for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Matrine for Injection Sales by Region (2027-2032)
  5. 6.3 Global Matrine for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Matrine for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Matrine for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Matrine for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Matrine for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Matrine for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Matrine for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Matrine for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Matrine for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Matrine for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Matrine for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Matrine for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Matrine for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Matrine for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Matrine for Injection Sales Value Share by Country, 2025 VS 2032
7 Matrine for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Matrine for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Matrine for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Matrine for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Matrine for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Matrine for Injection Sales by Country (2027-2032)
  6. 7.4 Global Matrine for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Matrine for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Matrine for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Matrine for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Matrine for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Matrine for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Matrine for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Matrine for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Matrine for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Matrine for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Matrine for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Matrine for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Matrine for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Matrine for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Matrine for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Matrine for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Matrine for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Matrine for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Matrine for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Matrine for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Matrine for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Matrine for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Matrine for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Matrine for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Matrine for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Matrine for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Matrine for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Matrine for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Matrine for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Matrine for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Matrine for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Matrine for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Matrine for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Matrine for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu Tiantai Mount Pharmaceutical
  2. 8.1.1 Chengdu Tiantai Mount Pharmaceutical Company Information
  3. 8.1.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
  4. 8.1.3 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu Tiantai Mount Pharmaceutical Matrine for Injection Product Portfolio
  6. 8.1.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
  7. 8.2 Henan Rongcheng Pharmaceutical
  8. 8.2.1 Henan Rongcheng Pharmaceutical Company Information
  9. 8.2.2 Henan Rongcheng Pharmaceutical Business Overview
  10. 8.2.3 Henan Rongcheng Pharmaceutical Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Henan Rongcheng Pharmaceutical Matrine for Injection Product Portfolio
  12. 8.2.5 Henan Rongcheng Pharmaceutical Recent Developments
  13. 8.3 Jiuquan Dadeli Pharmaceutical
  14. 8.3.1 Jiuquan Dadeli Pharmaceutical Company Information
  15. 8.3.2 Jiuquan Dadeli Pharmaceutical Business Overview
  16. 8.3.3 Jiuquan Dadeli Pharmaceutical Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Jiuquan Dadeli Pharmaceutical Matrine for Injection Product Portfolio
  18. 8.3.5 Jiuquan Dadeli Pharmaceutical Recent Developments
  19. 8.4 Nirvana Pharmaceutical
  20. 8.4.1 Nirvana Pharmaceutical Company Information
  21. 8.4.2 Nirvana Pharmaceutical Business Overview
  22. 8.4.3 Nirvana Pharmaceutical Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nirvana Pharmaceutical Matrine for Injection Product Portfolio
  24. 8.4.5 Nirvana Pharmaceutical Recent Developments
  25. 8.5 Trifecta Pharma Co. Ltd
  26. 8.5.1 Trifecta Pharma Co. Ltd Company Information
  27. 8.5.2 Trifecta Pharma Co. Ltd Business Overview
  28. 8.5.3 Trifecta Pharma Co. Ltd Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Trifecta Pharma Co. Ltd Matrine for Injection Product Portfolio
  30. 8.5.5 Trifecta Pharma Co. Ltd Recent Developments
  31. 8.6 CTTQ PHARMA
  32. 8.6.1 CTTQ PHARMA Company Information
  33. 8.6.2 CTTQ PHARMA Business Overview
  34. 8.6.3 CTTQ PHARMA Matrine for Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CTTQ PHARMA Matrine for Injection Product Portfolio
  36. 8.6.5 CTTQ PHARMA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Matrine for Injection Value Chain Analysis
  2. 9.1.1 Matrine for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Matrine for Injection Sales Mode & Process
  6. 9.2 Matrine for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Matrine for Injection Distributors
  9. 9.2.3 Matrine for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst